Edgewise Therapeutics, Inc. notified Nasdaq that it will no longer be in compliance with the Nasdaq Listing Rule due to a vacancy on the Audit Committee resulting from a director resignation.
AI Assistant
EDGEWISE THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.